Rare diseases
Investigational molecules
Locations
Sjukhusvagen 85, 751 85 Uppsala, Sweden
Research activity includes adrenocortical carcinoma, with interest in postoperative treatment strategies for high-risk disease and recurrence prevention after surgical resection.
Work in this area is centered on adjuvant mitotane and combination treatment approaches for patients with aggressive adrenal malignancy.
Uppsala University Hospital runs clinical trials in conditions such as Adrenocortical carcinoma, Malignant melanoma, Colorectal cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
France
FinlandSwedenIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
